PTC Authorizes $500M Buyback With Stock Near 52-Week Low
PTCT is trading near its 52-week low of $58.8 (4.4% above the low).
Summary
PTC's board cleared up to $500 million of common stock repurchases, roughly equal to the company's entire market value and backed by $2.13 billion in cash and marketable securities reported in the Q3 10-Q filed October 29. The authorization lands with shares at $61.39, near the 52-week low of $58.80 and well off the $90.87 high, and CEO Matthew Klein framed it as buying stock at a compelling price while keeping flexibility for business development. No repurchase is committed — management has discretion on timing and method, including open-market, negotiated or accelerated transactions. The size is the story: a buyback this large against a depressed share price is a real floor signal, though it follows a Q3 loss of $51.7 million driven by the $111.0 million ST-920 charge and a $19.3 million debt-extinguishment loss.
At the time of this announcement, PTCT was trading at $61.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $58.80 to $90.87. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.